Validity of Aspiration Prevention Surgery in Elderly Patients with Cerebrovascular or Neurodegenerative Disorders.

IF 3 3区医学 Q1 OTORHINOLARYNGOLOGY

Dysphagia Pub Date : 2025-09-18 DOI:10.1007/s00455-025-10889-1

Masahiko Y Kida, Mitsuyoshi Imaizumi, Toshiyuki Yamamoto

{"title":"Validity of Aspiration Prevention Surgery in Elderly Patients with Cerebrovascular or Neurodegenerative Disorders.","authors":"Masahiko Y Kida, Mitsuyoshi Imaizumi, Toshiyuki Yamamoto","doi":"10.1007/s00455-025-10889-1","DOIUrl":null,"url":null,"abstract":"<p><p>The risk of aspiration pneumonia has been reported to increase with age, especially in frail elderly patients with cerebrovascular and/or neurodegenerative disorders. To prevent this type of pneumonia, aspiration prevention surgery (APS) procedures have been demonstrated to be effective. However, the comprehensive efficacy of APS, not only in terms of survival rates, but also in terms of medical costs and caregiver burden, has not been fully evaluated in elderly patients requiring aspiration care. Thus, the aim of the current study was to demonstrate the validity of APS in elderly patients with cerebrovascular or neurodegenerative disorders. A total of 135 patients were enrolled; 82 with cerebrovascular disorders and 53 with neurodegenerative disorders, in whom APS was applied to 52 and 36 patients, respectively. The 2-year survival rates, medical costs, and number of suctioning procedures as a measure of caregiver burden were investigated in patients treated with APS (the APS group) and those without APS (the non-APS group). The 2-year survival rates for all patients were 53.4% in the APS group and 4.3% in the non-APS group. This result showed significantly better outcomes in the APS group. Moreover, in the APS group, the postoperative suction frequency showed a significant decrease compared to the preoperative suction frequency. Finally, medical costs were significantly lower in the APS group compared to the non-APS group. The results of this study demonstrate that APS contributed to improved survival rates, reduced medical costs, and a decrease in suctioning frequency in elderly patients with cerebrovascular or neurodegenerative diseases.</p>","PeriodicalId":11508,"journal":{"name":"Dysphagia","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dysphagia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00455-025-10889-1","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

The risk of aspiration pneumonia has been reported to increase with age, especially in frail elderly patients with cerebrovascular and/or neurodegenerative disorders. To prevent this type of pneumonia, aspiration prevention surgery (APS) procedures have been demonstrated to be effective. However, the comprehensive efficacy of APS, not only in terms of survival rates, but also in terms of medical costs and caregiver burden, has not been fully evaluated in elderly patients requiring aspiration care. Thus, the aim of the current study was to demonstrate the validity of APS in elderly patients with cerebrovascular or neurodegenerative disorders. A total of 135 patients were enrolled; 82 with cerebrovascular disorders and 53 with neurodegenerative disorders, in whom APS was applied to 52 and 36 patients, respectively. The 2-year survival rates, medical costs, and number of suctioning procedures as a measure of caregiver burden were investigated in patients treated with APS (the APS group) and those without APS (the non-APS group). The 2-year survival rates for all patients were 53.4% in the APS group and 4.3% in the non-APS group. This result showed significantly better outcomes in the APS group. Moreover, in the APS group, the postoperative suction frequency showed a significant decrease compared to the preoperative suction frequency. Finally, medical costs were significantly lower in the APS group compared to the non-APS group. The results of this study demonstrate that APS contributed to improved survival rates, reduced medical costs, and a decrease in suctioning frequency in elderly patients with cerebrovascular or neurodegenerative diseases.

查看原文本刊更多论文

预防误吸手术治疗老年脑血管或神经退行性疾病的有效性。

据报道，吸入性肺炎的风险随着年龄的增长而增加，特别是在患有脑血管和/或神经退行性疾病的体弱老年患者中。为了预防这种类型的肺炎，吸入预防手术（APS）程序已被证明是有效的。然而，在需要吸入性护理的老年患者中，APS的综合疗效（不仅在生存率方面，而且在医疗费用和护理人员负担方面）尚未得到充分评估。因此，本研究的目的是证明APS在老年脑血管或神经退行性疾病患者中的有效性。共有135名患者入组；脑血管疾病82例，神经退行性疾病53例，其中应用APS分别为52例和36例。对接受APS治疗的患者（APS组）和未接受APS治疗的患者（非APS组）的2年生存率、医疗费用和作为护理人员负担衡量指标的吸痰次数进行了调查。所有患者的2年生存率APS组为53.4%，非APS组为4.3%。结果显示，APS组的治疗效果明显更好。此外，APS组术后吸痰次数较术前明显减少。最后，与非APS组相比，APS组的医疗费用显著降低。本研究结果表明，APS有助于提高老年脑血管或神经退行性疾病患者的生存率，降低医疗费用，减少吸痰频率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Dysphagia 医学-耳鼻喉科学

CiteScore

4.90

自引率

15.40%

发文量

149

审稿时长

6-12 weeks

期刊介绍： Dysphagia aims to serve as a voice for the benefit of the patient. The journal is devoted exclusively to swallowing and its disorders. The purpose of the journal is to provide a source of information to the flourishing dysphagia community. Over the past years, the field of dysphagia has grown rapidly, and the community of dysphagia researchers have galvanized with ambition to represent dysphagia patients. In addition to covering a myriad of disciplines in medicine and speech pathology, the following topics are also covered, but are not limited to: bio-engineering, deglutition, esophageal motility, immunology, and neuro-gastroenterology. The journal aims to foster a growing need for further dysphagia investigation, to disseminate knowledge through research, and to stimulate communication among interested professionals. The journal publishes original papers, technical and instrumental notes, letters to the editor, and review articles.